advertisement

---

Contemporary clinical trials communications 1

Showing records 1 to 1 | Display all abstracts in Contemporary clinical trials communications

109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Mizuno Y; Komatsu K; Tokumo K; Okada N; Onoe H; Okumichi H; Hirooka K; Miura Y; Kiuchi Y
Contemporary clinical trials communications 2023; 33: 101160

---